MeSH Browser

MeSH Heading: Paraneoplastic Cerebellar Degeneration
Tree Number(s): C04.588.614.550.650; C04.730.856.650; C10.228.140.252.620; C10.574.781.700
Unique ID: D020362
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D020362
Annotation: coord with precoord organ/neopl term + histol type
Scope Note: Cerebellar degeneration associated with a remote neoplasm. Clinical manifestations include progressive limb and GAIT ATAXIA; DYSARTHRIA; and NYSTAGMUS, PATHOLOGIC. The histologic type of the associated neoplasm is usually carcinoma or lymphoma. Pathologically the cerebellar cortex and subcortical nuclei demonstrate diffuse degenerative changes. Anti-Purkinje cell antibodies (anti-Yo) are found in the serum of approximately 50% of affected individuals. (Adams et al., Principles of Neurology, 6th ed, p686)
Entry Version: PARANEOPL CEREBELLAR DEGENERATION
Entry Term(s): Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration; Cerebellar Degeneration, Paraneoplastic; Cerebellar Syndrome, Paraneoplastic; Paraneoplastic Cerebellar Degeneration, Anti-Yo-Associated; Paraneoplastic Cerebellar Syndrome
Previous Indexing: Cerebellar Ataxia (1975-1999); Paraneoplastic Syndromes (1980-1999)
Public MeSH Note: 2000
History Note: 2000
Date Established: 2000/01/01
Date of Entry: 1999/11/04
Revision Date: 2009/07/06

Allowable Qualifiers: blood (BL)

cerebrospinal fluid (CF)

chemically induced (CI)

classification (CL)

complications (CO)

congenital (CN)

diagnosis (DI)

diagnostic imaging (DG)

diet therapy (DH)

drug therapy (DT)

economics (EC)

embryology (EM)

enzymology (EN)

epidemiology (EP)

ethnology (EH)

etiology (ET)

genetics (GE)

history (HI)

immunology (IM)

metabolism (ME)

microbiology (MI)

mortality (MO)

nursing (NU)

parasitology (PS)

pathology (PA)

physiopathology (PP)

prevention & control (PC)

psychology (PX)

radiotherapy (RT)

rehabilitation (RH)

surgery (SU)

therapy (TH)

urine (UR)

veterinary (VE)

virology (VI)

Concept UI: M0328227
Scope Note: Cerebellar degeneration associated with a remote neoplasm. Clinical manifestations include progressive limb and GAIT ATAXIA; DYSARTHRIA; and NYSTAGMUS, PATHOLOGIC. The histologic type of the associated neoplasm is usually carcinoma or lymphoma. Pathologically the cerebellar cortex and subcortical nuclei demonstrate diffuse degenerative changes. Anti-Purkinje cell antibodies (anti-Yo) are found in the serum of approximately 50% of affected individuals. (Adams et al., Principles of Neurology, 6th ed, p686)
Terms: Paraneoplastic Cerebellar Degeneration Preferred Term
Term UI T358227
Date10/12/1999
LexicalTag NON
ThesaurusID; Cerebellar Syndrome, Paraneoplastic
Term UI T369816
Date10/12/1999
LexicalTag NON
ThesaurusID NLM (2000); Paraneoplastic Cerebellar Syndrome
Term UI T369817
Date10/12/1999
LexicalTag NON
ThesaurusID NLM (2000); Cerebellar Degeneration, Paraneoplastic
Term UI T369815
Date10/12/1999
LexicalTag NON
ThesaurusID NLM (2000)

Paraneoplastic Cerebellar Degeneration MeSH Descriptor Data 2024